Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis

被引:19
作者
Levy, Jerrold H. [1 ,22 ]
Sniecinski, Roman M. [2 ]
Rocca, Bianca [3 ]
Ghadimi, Kamrouz [4 ]
Douketis, James [5 ]
Frere, Corinne [6 ]
Helms, Julie [7 ,8 ]
Iba, Toshiaki [9 ]
Koster, Andreas [10 ]
Lech, Tara K. [11 ]
Maier, Cheryl L. [12 ]
Neal, Mathew D. [13 ]
Scarlestscu, Ecatarina [14 ]
Spyropoulos, Alex [15 ,16 ]
Steiner, Marie E. [17 ]
Tafur, Alfonso J. [18 ,19 ]
Tanaka, Kenichi A. [20 ]
Connors, Jean M. [21 ]
机构
[1] Duke Univ, Dept Anesthesiol Crit Care & Surg, Sch Med, Durham, NC USA
[2] Emory Univ, Dept Anesthesiol, Sch Med, Atlanta, GA USA
[3] Catholic Univ, Sch Med, Dept Safety & Bioeth, Sect Pharmacol, Rome, Italy
[4] Duke Univ, Sch Med, Dept Anesthesiol, Div Cardiothorac Anesthesiol & Crit Care,Clin Res, Durham, NC USA
[5] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Dept Med, Hamilton, ON, Canada
[6] Sorbonne Univ, Pttie Salpetriere Hosp, UMRS 1166, Paris, France
[7] Nouvel Hop Civil, Univ Hosp, Med Intens Care Unit, Strasbourg, France
[8] French Natl Inst Hlth & Med Res, UMR 1260, Regenerat Nanomed, FMTS, Strasbourg, France
[9] Juntendo Univ, Grad Sch Med, Dept Emergency & Disaster Med, Tokyo, Japan
[10] Ruhr Univ Bochum, Inst Anesthesiol & Pain Therapy, Heart & Diabet Ctr NRW, Bad Oeynhausen, Germany
[11] Beth Israel Lahey Hlth, Div Pharm, Westwood, MA USA
[12] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA USA
[13] Univ Pittsburgh, Trauma & Transfus Med Res Ctr, Dept Surg, Pittsburgh, PA USA
[14] Univ Med & Pharm Carol Davila, Fundeni Clin Inst, Dept Anaesthesia & Intens Care, Bucharest, Romania
[15] Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Med, Anticoagulat & Clin Thrombosis Serv, Hempstead, NY USA
[16] Northwell Hlth, Feinstein Inst Med Res, Inst Hlth Syst Sci, Manhasset, NY USA
[17] Univ Minnesota, Dept Pediat, Div Hematol Oncol & Crit Care, Minneapolis, MN USA
[18] NorthShore Univ Hlth Syst, Dept Med, Vasc Med, Evanston, IL USA
[19] Univ Chicago, Pritzker Sch Med, Chicago, IL USA
[20] Univ Oklahoma, Sch Med, Dept Anat, Oklahoma City, OK USA
[21] Harvard Med Sch, Brigham & Womens Hosp, Hematol Div, Boston, MA USA
[22] Duke Univ, Med Ctr, 2301 Erwin Rd,5691H HAFS,Box 3094, Durham, NC 27710 USA
关键词
anticoagulation; COVID-19; ECMO; heparin; resistance; sensitivity; EXTRACORPOREAL MEMBRANE-OXYGENATION; PARTIAL THROMBOPLASTIN TIME; ANTITHROMBOTIC THERAPY; CHEST GUIDELINE; XA; TRIAL;
D O I
10.1016/j.jtha.2023.08.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The term heparin resistance (HR) is used by clinicians without specific criteria. We performed a literature search and surveyed our SSC membership to better define the term when applied to medical and intensive care unit patients. The most common heparin dosing strategy reported in the literature (53%) and by survey respondents (80.4%) was the use of weight-based dosing. Heparin monitoring re-sults were similar based on the proportion of publications and respondents that reported the use of anti-Xa and activated partial thromboplastin time. The most common literature definition of HR was >35 000 U/d, but no consensus was re-ported among survey respondents regarding weight-based and the total dose of heparin when determining resistance. Respondent consensus on treating HR included antithrombin supplementation, direct thrombin inhibitors, or administering more heparin as the strategies available for treating HR. A range of definitions for HR exist. Given the common use of heparin weight-based dosing, future publica-tions employing the term HR should include weight-based definitions, monitoring assay, and target level used. Further work is needed to develop a consensus for defining HR.
引用
收藏
页码:3649 / 3657
页数:9
相关论文
共 31 条
[1]   A Prospective Pilot Trial to Assess the Efficacy of Argatroban (Argatra®) in Critically Ill Patients with Heparin Resistance [J].
Bachler, Mirjam ;
Hell, Tobias ;
Boesch, Johannes ;
Treml, Benedikt ;
Schenk, Bettina ;
Treichl, Benjamin ;
Friesenecker, Barbara ;
Lorenz, Ingo ;
Stengg, Daniel ;
Hruby, Stefan ;
Wallner, Bernd ;
Oswald, Elgar ;
Stroehle, Mathias ;
Niederwanger, Christian ;
Irsara, Christian ;
Fries, Dietmar .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
[2]   Evaluation of heparin infusion rates in patients with intravenous drug misuse [J].
Barga, Kenneth ;
Smith, Adam ;
Faherty, Mallory ;
Crawford, Katherine .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 53 (04) :959-964
[3]   Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2 [J].
Beun, Robert ;
Kusadasi, Nuray ;
Sikma, Maaike ;
Westerink, Jan ;
Huisman, Albert .
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2020, 42 :19-20
[4]   Low-Molecular-Weight Heparin Resistance and Its Viscoelastic Assessment in Critically Ill COVID-19 Patients [J].
Boesch, Johannes ;
Rugg, Christopher ;
Schaefer, Volker ;
Lichtenberger, Philipp ;
Staier, Nikolai ;
Treichl, Benjamin ;
Rajsic, Sasa ;
Peer, Andreas ;
Schobersberger, Wolfgang ;
Fries, Dietmar ;
Bachler, Mirjam .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2022, 48 (07) :850-857
[5]   Heparin resistance in severe thermal injury: A prospective cohort study [J].
Cato, Liam D. ;
Bailiff, Benjamin ;
Price, Joshua ;
Ermogeneous, Christos ;
Hazeldine, Jon ;
Lester, William ;
Lowe, Gillian ;
Wearn, Christopher ;
Bishop, Jonathan R. B. ;
Lord, Janet M. ;
Moiemen, Naiem ;
Harrison, Paul .
BURNS & TRAUMA, 2021, 9
[6]   Heparin Resistance in SARS-CoV-2 Infected Patients with Venous Thromboembolism [J].
Chau, Terence ;
Joseph, Merlyn ;
Solomon, Diana M. ;
Lee, Bryan ;
Igneri, Lauren A. .
HOSPITAL PHARMACY, 2022, 57 (06) :737-743
[7]   Diagnosis and Management of the Antiphospholipid Syndrome [J].
Riera-Mestre, Antoni ;
Vidaller, Antonio .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (13) :1289-1290
[8]   Parenteral Anticoagulants Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J].
Garcia, David A. ;
Baglin, Trevor P. ;
Weitz, Jeffrey I. ;
Samama, Meyer Michel .
CHEST, 2012, 141 (02) :E24S-E43S
[9]  
Gionis MN, 2016, INT ANGIOL, V35, P170
[10]  
HAGEDORN AB, 1947, J LAB CLIN MED, V32, P1087